Diagnostic evaluation and management of obscure overt haemorrhage in a Jehovah’s witness patient: a case report and review of the literature

Authors

  • Rahul Menon Department of General Surgery, Ipswich Hospital, Ipswich, QLD, Australia

DOI:

https://doi.org/10.18203/2349-2902.isj20241743

Keywords:

Obscure haemorrhage, Upper gastrointestinal surgery, Bloodless transfusion, Jehovah’s witness

Abstract

Metastasis of cutaneous malignancies to the small intestine is rare with only up to 4.7% found in antemortem patients. The most common presenting symptoms is obstruction or intussusception whilst obscure overt haemorrhage is rare. Acute haemorrhage progressing to hypovolaemic shock is a serious and preventable issue and can be prevented by addressing the underlying cause and with the judicious use of blood products. However, in certain populations such as Jehovah’s witnesses, the administration of blood products is forbidden. In the acute surgical patient who was in acute haemorrhagic hypovolaemic shock, blood-less transfusion methods included early identification of wishes, diagnosis and treatment, intraoperative cell salvage and normovolaemic haemodilution, antifibrinolytics, intraoperative sealants, and optimal surgical technique. This report described the diagnosis and management of the case of a 62-year-old male patient who presented with severe obscure overt haemorrhage and a haemoglobin nadir of 3.7 g/dl who declined blood products. This patient had unremarkable imaging findings on CT and no embolization target despite a jejunal mass with active arterial blush. Diagnostic laparoscopy with on-table push enteroscopy identified an ulcerated jejunal lesion that was subsequently resected. Histopathological assessment of the specimen revealed a diagnosis of metastatic melanoma. The patient ultimately received palliative chemotherapy and immunotherapy. To improve early diagnosis of small-bowel metastases, a combination of imaging techniques is recommended for patients with a history of cutaneous melanoma who have obscure gastrointestinal bleeding, anaemia, and other non-specific abdominal symptoms.

References

Panagiotou I, Brountzos EN, Bafaloukos D, Stoupis C, Brestas P, Kelekis DA. Malignant melanoma metastatic to the gastrointestinal tract. Melanoma Res. 2002;12(2):169-73.

Schuchter LM, Green R, Fraker D. Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract. Curr Opin Oncol. 2000;12(2):181-5.

Nunez TC, Cotton BA. Transfusion therapy in hemorrhagic shock. Curr Opin Crit Care. 2009;15(6):536-41.

Pew Research Center. Share of global population affiliated with major religious groups 2022. Pew Res Center. 2023.

Watch Tower Bible and Tract Society of Pennsylvania. Service Year Report of Jehovah’s Witnesses Worldwide 2023. Available at: https://www.jw.org/en/jehovahs-witnesses/faq/how-many-jw/. Accessed on 1 April 2024.

Thompson HA. Blood transfusions and Jehovah’s Witnesses. Tex Med. 1989;85(4):57-9.

Frank SM, Wick EC, Dezern AE, Ness PM, Wasey JO, Pippa AC, et al. Risk-adjusted clinical outcomes in patients enrolled in a bloodless program. Transfusion (Paris). 2014;54:2668-77.

Resar LMS, Wick EC, Almasri TN, Dackiw EA, Ness PM, Frank SM. Bloodless medicine: current strategies and emerging treatment paradigms. Transfusion (Paris). 2016;56(10):2637-47.

Resar LMS, Frank SM. Bloodless medicine: what to do when you can’t transfuse. Hematology. 2014;2014(1):553-8.

Zuckerman GR, Prakash C, Askin MP, Lewis BS. AGA technical review on the evaluation and management of occult and obscure gastrointestinal bleeding. Gastroenterology. 2000;118(1):201-21.

Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. N Engl J Med. 1993;329(23):1691-5.

Lieberman JA, Weiskopf RB, Kelley SD, Feiner J, Noorani M, Leung J, et al. Critical oxygen delivery in conscious humans is less than 7.3 ml O2 x kg(-1) x min(-1). Anesthesiology. 2000;92(2):407-13.

Jensen FB. The dual roles of red blood cells in tissue oxygen delivery: oxygen carriers and regulators of local blood flow. J Exp Biol. 2009;212(21):3387-93.

Raju GS, Gerson L, Das A, Lewis B. American Gastroenterological Association (AGA) Institute technical review on obscure gastrointestinal bleeding. Gastroenterology. 2007;133(5):1697-717.

Estévez E, González-Conde B, Vázquez-Iglesias JL, Vázquez-Millán M, Pértega S, Alonso PA, et al. Diagnostic yield and clinical outcomes after capsule endoscopy in 100 consecutive patients with obscure gastrointestinal bleeding. Eur J Gastroenterol Hepatol. 2006;18(8):881-8.

MacLaren G, Anderson M. Bloodless intensive care: a case series and review of Jehovah’s Witnesses in ICU. Anaesth Intensive Care. 2004;32(6):798-803.

Atabek U, Alvarez R, Pello MJ, Alexander JB, Camishion RC, Curry C, et al. Erythropoetin accelerates hematocrit recovery in post-surgical anemia. Am Surg. 1995;61(1):74-7.

McLoughlin PL, Cope TM, Harrison JC. Hyperbaric oxygen therapy in the management of severe acute anaemia in a Jehovah’s witness. Anaesthesia. 1999;54(9):891-5.

McLoughlin P.L. Hyperbaric oxygen therapy in the management of severe acute anaemia in a Jehovah's witness. Anaesthesia. 1999;54(9):891-5.

Downloads

Published

2024-06-27

Issue

Section

Case Reports